Allocations
Hunter Street Partners (Hunter Street), a Minneapolis-based alternative investment management firm, has launched a scalable platform to invest in equipment rental companies.
Hunter Street has acquired All-Star Equipment Rental of Naples (All-Star), a single-site operator based in Southwest Florida, and will work closely with the company’s management team to evaluate other opportunities for expansion in the region.
All-Star rents, sells, and services equipment including but not limited to forklifts, boom lifts, mini-excavators, skid steers, scissor lifts, and an extensive offering of small equipment. All-Star serves a range of commercial end-markets including construction, renovation, landscaping, energy, milling, and agriculture companies in
VNX Exchange, a Luxembourg-based digital asset investment platform, has completed the first VC deal in Europe utilising blockchain tech.
The deal sees the issue of EUR1.1 million of asset-backed tokens linked to the investment into Streami Inc, a South Korean blockchain company.
Issued on the Ethereum blockchain ERC-20, the asset-backed tokens represent claims on the future cash flow from the investment.
“This digital solution was very useful for fundraising when faced with the new reality brought by the pandemic, lockdown and travel bans,” said Junhaeng Lee, co-founder and CEO of Streami.
Streami is a parent company to a South Korean
A company backed by global private equity firm Permira, has agreed to acquire Neuraxpharm, a European specialty pharmaceutical company focused on the treatment of the central nervous system (CNS) from funds advised by Apax Partners. Financial details of the transaction have not been disclosed.
With its unique understanding of the CNS market built over 35 years, Neuraxpharm develops and commercialises value-added medicines and consumer healthcare products for chronic patients suffering from neurological and psychiatric disorders including Epilepsy, Parkinson’s, Alzheimer’s, Depression and Psychosis. With one of the broadest and most diversified product portfolios in the market, its strong medical reputation and
ARQIS has advised AVS Verkehrssicherung on the acquisition of SRV Verkehrstechnik.SRV was founded in 1990 to meet the high demand for infrastructure services in the former East German states. The professional application of white or yellow road markings in paint, hot or cold plastic is the specialty of SRV. Services in the field of traffic safety and the necessary road equipment complete the portfolio.
AVS Verkehrssicherung, headquartered in Leverkusen, is a leading specialist provider of traffic safety services in Germany and Europe. The company is represented at over 25 locations in Germany and internationally at more than 10 locations
AMP Capital has agreed to acquire a majority stake in VX Fiber, an international infra tech fibre business headquartered in Sweden, on behalf of investors in its infrastructure equity strategy. VX Fiber has existing operations in South Africa and the UK and is targeting an advanced pipeline of opportunities in the UK, Belgium, Austria and Germany.
VX Fiber designs, builds and operates full fibre FTTP (Fibre-To-The-Premise) open access networks globally and has developed its own proprietary software platform which it operates on third parties’ passive fibre infrastructure as fibre operator. The entire network is remotely run through a network operations centre
Funds advised by Apax Partners (the “Apax Funds”) have agreed to sell their controlling stake in Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system disorders (CNS), to funds advised by Permira. Financial details of the transaction have not been disclosed.
With a heritage dating back 35 years, Neuraxpharm focuses on improving the quality of life and mental wellbeing of patients affected by CNS disorders throughout Europe. Neuraxpharm has operations in 13 countries and covers 80% of the European CNS drug market today. The company has one of the most comprehensive product portfolios
Medicxi, a European life sciences investment firm, has held the closing of Medicxi Secondary 1 (MS1) in connection with the completion of an “Exit & Reinvest” type of structured secondary transaction. The interests in six clinical and preclinical stage companies held by Index Ventures Life VI, a dedicated life sciences fund advised by Medicxi, were acquired by a newly formed fund managed by Medicxi, called MS1. The new fund has been anchored by leading secondary investor, Pantheon (London), with LGT Capital Partners (Pfaeffikon, Switzerland) as co-lead investor.
The portfolio was acquired by MS1 at a premium to its net asset value.
Odyssey Investment Partners (Odyssey) is to acquire ProPharma Group from Linden Capital Partners. Financial terms of the transaction have not been disclosed. Founded in 2001, ProPharma Group is a leading provider of regulatory and compliance services to pharmaceutical, biotechnology and medical device customers. The Company’s primary service offerings include regulatory affairs, life science consulting, pharmacovigilance and medical information services. ProPharma Group partners with its clients from early concept development through each clinical phase, product launch, and commercialisation to help ensure regulatory expectations are met, business goals are achieved, and patient health and safety is improved. ProPharma Group is headquartered in Overland
BGF is investing in Calnex Solutions plc, an established provider of test and measurement solutions for the global telecommunications sector, as part of its proposed admission to trading on AIM. The admission is expected to take place on 5 October 2020.
Headquartered in Linlithgow and founded in 2006, Calnex designs and makes equipment that tests the performance of telecom network infrastructure for customers including BT, Ericsson, Nokia and Facebook. To date, Calnex has secured and delivered orders from over 600 customer sites in 68 countries across the world. The telecoms industry is currently experiencing unprecedented levels of change because of
Private investment firm Auxo Investment Partners has partnered with existing management to acquire Paramount Tube and Euclid Medical, which operate under the Precision Products Group (PPG) brand. The deal, terms of which have not been disclosed, marks Auxo’s seventh acquisition in the firm’s inaugural investment fund, Auxo Growth Holdings I LLC, which closed in the fall of 2018.
Paramount Tube is the dominant player for mission-critical, small diameter spiral-wound and extruded tubular products known for providing highly customized, tight tolerance and uniquely shaped solutions. Applications include components for electric motors, transformers, fuses, automotive, single-dosage medications, pharmaceutical packaging, eco-friendly consumer packaging,
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
